The role of LOXL2 and BRD4 in DNA damage and their cooperation in controlling the transcriptional regulation of cell cycle progression may suggest that their simultaneous inhibition in tumor cells could act as a double‐edged sword. The gene discussed is BRD4; the disease is neoplasm.